Aquaculture-Seafood

Large-scale cultivation and processing of macroalgae (seaweed) into sustainable biopolymers, animal feed additives, and biofuels, decoupling production from terrestrial land and freshwater.

Bioactive peptides, low-molecular-weight collagen and omega-3 recovered from fishery by-catch (heads, skin, bones) by enzymatic hydrolysis, tangential ultrafiltration and spray-drying — a circular-blue-economy stack for nutraceuticals, cosmeceuticals and functional food.

Cultivating microalgae to produce sustainable omega-3 oils and protein for aquafeed and human nutrition.

Microalgae-derived carotenoids — natural astaxanthin from Haematococcus pluvialis and beta-carotene from Dunaliella salina — produced as high-concentration oleoresins and supplement ingredients by dedicated cultivators in the USA, India, Austria and Iceland.

Microalgae-derived EPA and DHA omega-3 oils — from Crypthecodinium, Nannochloropsis and Schizochytrium — produced as vegan nutraceutical and infant-nutrition ingredients by DSM-Firmenich, Qualitas Health, Fermentalg and Kingdomway.

Moving fish farming into exposed, high-energy waters with submersible steel cages, autonomous vessel-farms and AI feeding, de-risked by NS 9415 cage hydrodynamics and integrated multi-trophic aquaculture (IMTA) to cut nitrogen load, under NOAA/EPA, EU EIA and China's deep-sea aquaculture programmes.

Plant-protein isolates, fermented mycoprotein and seaweed are extruded and 3D-structured into whole-cut and canned seafood substitutes — a route distinct from cell-cultured seafood (cultured-seafood), marine peptides (marine-peptides-nutraceuticals) and microalgal protein (microalgae-aquaculture), driven by 2026 scale-up milestones: Revo Foods' TASTE FACTORY in Vienna, BettaF!sh's cross-Atlantic acquisition by Bayou Best Foods, and Oshi's 3 million dollar raise.